Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
about
Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsAsian consensus on the relationship between obesity and gastrointestinal and liver diseases.Transient elastography as a screening tool for liver fibrosis in a large hemodialysis populationNAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.1H Magnetic Resonance Spectroscopy Predicts Hepatocellular Carcinoma in a Subset of Patients With Liver Cirrhosis: A Randomized Trial.An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia.Hepatic fat content is a determinant of metabolic phenotypes and increased carotid intima-media thickness in obese adultsHealth and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.Advances in noninvasive methods for diagnosing nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease in Asia: emerging perspectives.Exosomal miRNAs as biomarkers in the diagnosis of liver disease.Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study.Bi-directional analysis between fatty liver and cardiovascular disease risk factors.Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study.Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.Association between physical activity and risk of nonalcoholic fatty liver disease: a meta-analysis.Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study.Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population.Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions.Nonalcoholic Fatty Liver Disease Incidence and Impact on Metabolic Burden and Death: a 20 Year-Community Study.Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease.Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease.Editorial: non-alcoholic fatty liver disease-it is better to be slender after all.Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up.
P2860
Q26748608-EFE7B2E1-A0C4-4E3B-880F-33D7C8616037Q30251719-01892BA7-95D8-4E81-B6C1-EF5D663D99F2Q33577504-C4328E19-C2D3-4BDA-BBB6-5D6EAA522602Q33844463-8BDF3C89-90EB-4CBD-B8DA-4FF062F179D1Q35858262-0C457EDB-AB45-411A-B744-3398A08C0E59Q36405031-D446E329-5D7D-4686-95FD-33FE32E7109FQ36605880-E4BBBC50-5E46-4E3A-BC12-693FAE761117Q38642356-9AE03BE3-130C-4035-BCAA-3FA9D9A76B0CQ38676257-785407EB-97FC-441A-B837-AE4E87101236Q38791485-F1D46A23-8CFC-48AB-AAD4-B41978EEA69DQ38900960-A2A24961-EC81-47EF-A420-DEF4753951EBQ38956717-F02AC4F5-F895-45BC-8597-854D3EA74ABFQ39361895-6862AE91-27A6-4279-857F-4DD822B48A6FQ39658315-10E73347-033F-421E-AB24-CD0A4C38F533Q40501773-8189DF89-04A9-49E8-B180-8888EBD18B72Q40546061-503D5DC2-A696-4079-9502-FE579ACDCE09Q40705552-AC020E01-C309-43B4-B80E-6443F1D8B5E9Q41073361-6CD5D88E-749E-402A-BF73-7B52C80B0B32Q41078413-99AFB8BA-82CD-4874-A128-C263BD3A3BA4Q45711780-6F7F20BD-45B0-4ED6-B069-545E295DD03FQ45947181-DC392E29-EA9E-451C-9653-01C9998EF780Q46476704-7CDEA895-5363-4868-97F3-B01DF4555AA5Q47935385-9C366B92-810F-46E1-86F1-7638A4CD1438Q47942345-F6030DCB-C811-42A0-B0E4-3388A0DD58BFQ48169110-B201F9F9-E8EE-433E-88B9-7A9A91A59237Q48187865-B3C7EBC5-BB16-4801-8C8D-65FD5AEEF370Q48371285-47827DD0-52EF-4CA0-B050-B4C9465A872CQ55315636-98F2BD6D-2743-4670-8D77-175D97CF8D51
P2860
Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Incidence of non-alcoholic fat ...... gnetic resonance spectroscopy.
@en
Incidence of non-alcoholic fat ...... gnetic resonance spectroscopy.
@nl
type
label
Incidence of non-alcoholic fat ...... gnetic resonance spectroscopy.
@en
Incidence of non-alcoholic fat ...... gnetic resonance spectroscopy.
@nl
prefLabel
Incidence of non-alcoholic fat ...... gnetic resonance spectroscopy.
@en
Incidence of non-alcoholic fat ...... gnetic resonance spectroscopy.
@nl
P2093
P50
P1476
Incidence of non-alcoholic fat ...... agnetic resonance spectroscopy
@en
P2093
Angel Mei-Ling Chim
Carmen Ka-Man Chan
David Ka-Wai Yeung
Grace Lai-Hung Wong
Henry Lik-Yuen Chan
Ruth Suk-Mei Chan
Tina Kit-Ting Lau
Vincent Wai-Sun Wong
Yee-Kit Tse
P304
P356
10.1016/J.JHEP.2014.08.041
P577
2014-09-06T00:00:00Z